Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Anthera Pharmaceuticals Inc | 84,705 | reported | 05 Jan 2018 | tx 87+8,649,915−1,891,750 |
| Milestone Pharmaceuticals Inc. | 53,088 | reported | 31 May 2022 | tx 12+130,780−76,780 |
| CymaBay Therapeutics, Inc. | 32,000 | reported | 26 Jan 2021 | tx 8+177,450 |
| Trius Therapeutics Inc | 0 | reported | 11 Sept 2013 | tx 15+61,364−84,037 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 31 May 2022 | PURCHASE | Milestone Pharmaceuticals Inc. | 5,000 | 5.60 USD | first after silence |
| 31 May 2022 | EXERCISE | Milestone Pharmaceuticals Inc. | 822 | 2.66 USD | |
| 31 May 2022 | EXERCISE | Milestone Pharmaceuticals Inc. | 22,870 | 1.54 USD | |
| 31 May 2022 | EXERCISE | Milestone Pharmaceuticals Inc. | 45,072 | 1.54 USD | |
| 31 May 2022 | EXERCISE | Milestone Pharmaceuticals Inc. | 8,016 | 1.12 USD | |
| 31 May 2022 | EXERCISE | Milestone Pharmaceuticals Inc. | 22,870 | 0.00 USD | deriv |
| 31 May 2022 | EXERCISE | Milestone Pharmaceuticals Inc. | 8,016 | 0.00 USD | deriv |
| 31 May 2022 | EXERCISE | Milestone Pharmaceuticals Inc. | 45,072 | 0.00 USD | deriv |
| 31 May 2022 | EXERCISE | Milestone Pharmaceuticals Inc. | 822 | 0.00 USD | deriv |
| 14 Jun 2021 | GRANT_AWARD | Milestone Pharmaceuticals Inc. | 30,000 | 0.00 USD | deriv |
| 26 Jan 2021 | GRANT_AWARD | CymaBay Therapeutics, Inc. | 32,000 | 0.00 USD | deriv |
| 05 Jun 2020 | GRANT_AWARD | Milestone Pharmaceuticals Inc. | 15,000 | 0.00 USD | deriv |
| 15 May 2020 | GRANT_AWARD | CymaBay Therapeutics, Inc. | 49,245 | 0.00 USD | deriv |
| 12 Nov 2019 | GRANT_AWARD | Milestone Pharmaceuticals Inc. | 4,000 | 0.00 USD | deriv |
| 29 Jan 2019 | GRANT_AWARD | CymaBay Therapeutics, Inc. | 27,705 | 0.00 USD | deriv |
| 24 Jan 2018 | GRANT_AWARD | CymaBay Therapeutics, Inc. | 16,000 | 0.00 USD | deriv |
| 05 Jan 2018 | GRANT_AWARD | Anthera Pharmaceuticals Inc | 84,705 | 0.00 USD | deriv |
| 05 Jan 2018 | GRANT_AWARD | Anthera Pharmaceuticals Inc | 84,705 | 0.00 USD | deriv |
| 22 Sept 2017 | GRANT_AWARD | CymaBay Therapeutics, Inc. | 7,500 | 0.00 USD | deriv |
| 07 Sept 2017 | PURCHASE | Anthera Pharmaceuticals Inc | 5,000 | 1.34 USD | first after silence |
| 28 Jun 2017 | GRANT_AWARD | CymaBay Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 19 May 2017 | OTHER | Anthera Pharmaceuticals Inc | 84,376 | 0.00 USD | deriv |
| 19 May 2017 | OTHER | Anthera Pharmaceuticals Inc | 1,369 | 0.00 USD | deriv |
| 19 Jan 2017 | GRANT_AWARD | CymaBay Therapeutics, Inc. | 12,000 | 0.00 USD | deriv |
| 02 Dec 2016 | OTHER | Anthera Pharmaceuticals Inc | 180,000 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 31 May 2022.